Tacrolimus & COVID-19

4.9%

of users reported COVID-19

44.2%

also reported Hospitalization

63.3%

are men

Hospitalization

44.2%

Severe reaction

41.9%

Death

11.9%

Life-threatening condition

2.1%

Tacrolimus: general information

0 - 9 years

4.9%

10 - 19 years

8.5%

20 - 29 years

6.8%

30 - 39 years

10.9%

40 - 49 years

13.0%

50 - 59 years

22.0%

60 - 69 years

21.4%

70 - 79 years

11.8%

80 - 89 years

0.6%